Anti-CD9 antibody [EPR23105-125]
- BOND RX™ Validated
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(64 Publications)
Anti-CD9 antibody [EPR23105-125] (ab263019) is a rabbit monoclonal antibody detecting CD9 in Western Blot, Flow Cytometry, IP, IHC-P. Suitable for Human.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications
View Alternative Names
CD9, MIC3, TSPAN29, GIG2, CD9 antigen, 5H9 antigen, Cell growth-inhibiting gene 2 protein, Leukocyte antigen MIC3, Motility-related protein, Tetraspanin-29, p24, MRP-1, Tspan-29
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD9 antibody [EPR23105-125] (AB263019)
Immunohistochemical analysis of paraffin-embedded Human cervical carcinoma tissue labeling CD9 with ab263019 at 1/1000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on human cervical carcinoma. The section was incubated with ab263019 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20mins.
- Flow Cyt
Unknown
Flow Cytometry - Anti-CD9 antibody [EPR23105-125] (AB263019)
Flow cytometric analysis of Raji (human Burkitt's lymphoma B lymphocyte, Left) / HCT 116 (human colorectal carcinoma epithelial cell, Right) cells labelling CD9 with ab263019 at 1/500 dilution compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 was used as the secondary antibody.
Negative control : Raji (PMID : 8921952).
Gated on viable cells.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD9 antibody [EPR23105-125] (AB263019)
Immunohistochemical analysis of paraffin-embedded Human spleen tissue labeling CD9 with ab263019 at 1/1000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on platelets of human spleen. The section was incubated with ab263019 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
- IP
Unknown
Immunoprecipitation - Anti-CD9 antibody [EPR23105-125] (AB263019)
CD9 was immunoprecipitated from 0.35 mg HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate with ab263019 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab263019 at 1/500 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/1000 dilution.
Lane 1 : HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate 10ug.
Lane 2 : ab263019 IP in HCT 116 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab263019 in HCT 116 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 10 seconds.
All lanes:
Immunoprecipitation - Anti-CD9 antibody [EPR23105-125] (ab263019)
Predicted band size: 25 kDa
Observed band size: 22 kDa
false
- WB
Lab
Western blot - Anti-CD9 antibody [EPR23105-125] (AB263019)
Lanes 1 - 4 : Merged signal (red and green). Green - ab263019 observed at 18 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55 kDa.
ab263019 was shown to react with CD9 in wild-type HeLa cells in Western blot with loss of signal observed in CD9 knockout cell line ab255375 (CD9 knockout cell lysate ab263754). Wild-type HeLa and CD9 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with ab263019 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-CD9 antibody [EPR23105-125] (ab263019) at 1/1000 dilution
Lane 1:
Wild-type HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
CD9 knockout HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
Western blot - Human CD9 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-cd9-knockout-hela-cell-line-ab255375'>ab255375</a>)
Lane 3:
A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 4:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Predicted band size: 25 kDa
Observed band size: 18 kDa
false
- WB
Lab
Western blot - Anti-CD9 antibody [EPR23105-125] (AB263019)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The molecular weight observed is consistent with what has been described in the literature (PMID : 3275469). Exposure time : 3 minutes.
All lanes:
Western blot - Anti-CD9 antibody [EPR23105-125] (ab263019) at 1/1000 dilution
Lane 1:
HEL (erythroleukemia erythroblast), whole cell lysate at 20 µg
Lane 2:
Human tonsil lysate at 20 µg
Lane 3:
Human colon lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 25 kDa
Observed band size: 22 kDa
false
- WB
Lab
Western blot - Anti-CD9 antibody [EPR23105-125] (AB263019)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The molecular weight observed is consistent with what has been described in the literature (PMID : 3275469).
Negative control : Raji (PMID : 8921952). Exposure time : 3 minutes.
All lanes:
Western blot - Anti-CD9 antibody [EPR23105-125] (ab263019) at 1/1000 dilution
Lane 1:
HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Raji (human Burkitts lymphoma B lymphocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 25 kDa
Observed band size: 22 kDa
false
Related conjugates and formulations (3)
-
Anti-CD9 antibody [EPR23105-125] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD9 antibody [EPR23105-125]
-
578 PE
PE Anti-CD9 antibody [EPR23105-125]
Reactivity data
Product details
Product Specifications
Anti-CD9 antibody [EPR23105-125] (ab263019) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt, IHC-P, IP, WB in human samples.
Anti-CD9 antibody [EPR23105-125] (ab263019) specifically detects CD9 (UniProt ID: P21926; Molecular weight: 25kDa) and is sold in 100 µL and 1 mL selling sizes.
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-CD9 antibody [EPR23105-125] (ab263019) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-CD9 antibody [EPR23105-125] (ab263019) has been confirmed by testing in knockout samples.
Anti-CD9 antibody [EPR23105-125] (ab263019) has been cited over 22 times in peer reviewed journals and is trusted by the scientific community.
Related Products
Conjugation-ready, carrier free format available for antibody clone EPR23105-125 - ab263024.
Antibody clone EPR23105-125 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488 (ab316875).
Target Information
CD9 also known as p24 is a member of the tetraspanin family, which includes proteins involved in various cellular processes. CD9 (p24) plays a significant role in cancer progression and metastasis by influencing cell adhesion, migration, and signaling. CD9 (p24) is found on the surface of cancer cells and within exosomes, impacting cancer progression and therapy resistance. CD9's role in cancer is complex, as it can both suppress and promote tumor growth depending on the context. The protein's interactions within tetraspanin-enriched microdomains (TEMs) are crucial for its function.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The CD9 protein is integral to cell adhesion migration and fusion. It forms complexes with other tetraspanins and proteins like EWI-2 and EWI-F contributing to cellular signaling and membrane compartmentalization. Additionally CD9 plays an important role in the formation and secretion of exosomes tiny vesicles emitted by cells that mediate cell-to-cell communication. These exosomes can be analyzed using tools like exosome assays and detection kits that target CD9 proteins.
Pathways
CD9 is involved in the regulation of immune response and cell morphology. It participates in pathways such as the integrin signaling pathway and the phosphatidylinositol 3-kinase (PI3K) signaling pathway. CD9 modulates these interactions by associating with proteins such as integrins and other members of the tetraspanin family influencing cellular movement and proliferation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (64)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 26: PubMed41009408
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biology 14: PubMed40906403
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 31:278 PubMed40819077
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:29273 PubMed40784956
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 29:e70725 PubMed40770945
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of extracellular vesicles 14:e70099 PubMed40545968
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology and toxicology 41:103 PubMed40515797
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell and tissue research 401:275-286 PubMed40481270
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of cell biology 224: PubMed40304687
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmaceutica Sinica. B 15:1007-1022 PubMed40177564
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com